US Rx Spending Growth Projected To Stay Modest; Will Political Debate Change?

The latest update by the US Centers for Medicare & Medicaid Services to national health care spending forecasts continues to put prescription drugs in line with – or even slightly below – overall growth rates. Of course, that likely won’t change the political attention to the issue in 2022.

Drug Pricing in Washington's landscape
The drug pricing debate is a permanent fixture of Washington's landscape, regardless of what the prices actually are. • Source: Nielsen Hobbs; the Pink Sheet | Getty, Shutterstock images

More from Pricing Debate

More from Market Access